Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019

BILLERICA, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2018.  The webcast will be live at: https://edge.media-server.com/m6/p/tn6ktdfr.

The webcast will be hosted by Mark Augusti, President and Chief Executive Officer, and Paul Weiner, Chief Financial Officer.  The Company will issue a news release announcing its fourth quarter and fiscal year 2018 financial results on Wednesday, February 6, 2019, prior to the webcast.

The online archive of the webcast will be available on the company’s website at ir.conformis.com for 30 days.   

About Conformis, Inc.

Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. Conformis offers a broad line of customized knee and hip implants and customized pre-sterilized, single-use instruments delivered in a single package to the hospital. In clinical studies, Conformis iTotal CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants.  Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover customized implants and customized patient-specific instrumentation for all major joints.

For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com/.

Contact

Investor Contact:
Investor Relations
ir@conformis.com 
(781) 374-5598

Primary Logo